Concepedia

Zhongkai Shi

ZS

Statistics

Publications

12

Citations

1K

H-Index

12

Active since

1997

Affiliations

University of Alabama at Birmingham(Current)

University of Cape Town

Statens Serum Institut

South African Tuberculosis Vaccine Initiative

Aeras

Zhongkai Shi is an author at University of Alabama at Birmingham specializing in medicine, vaccination, and immunology.

Top concepts

Publications per year

1997–2018

12

Publications

12

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans

Kent R. Van Kampen, Zhongkai Shi, Peng Gao et al. · Vaccine · 2004 · 222 citations

, , +9

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Angelique Kany Kany Luabeya, Benjamin M. Kagina, Michèle Tameris et al. · Vaccine · 2015 · 190 citations

, , +11

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial

Sara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 112 citations

DNA-based non-invasive vaccination onto the skin

Zhongkai Shi, David T Curiel, De‐chu C. Tang · Vaccine · 1999 · 87 citations

, , +6

The tuberculosis vaccine H4:IC31 is safe and induces a persistent polyfunctional CD4 T cell response in South African adults: A randomized controlled trial

Hennie Geldenhuys, Helen Mearns, David J. C. Miles et al. · Vaccine · 2015 · 79 citations

, , +8

Rows per page

1–5 of 12